HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincent H L Ip Selected Research

Rituximab (Mabthera)

1/2013Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincent H L Ip Research Topics

Disease

2Stroke (Strokes)
03/2023 - 03/2015
1Pathologic Constriction (Stenosis)
03/2015
1Parkinson Disease (Parkinson's Disease)
12/2014
1Carotid Stenosis (Carotid Artery Stenosis)
02/2013
1Neuromyelitis Optica (Devic's Disease)
01/2013

Drug/Important Bio-Agent (IBA)

1Indicators and Reagents (Reagents)IBA
03/2023
1Rituximab (Mabthera)FDA Link
01/2013

Therapy/Procedure

1Therapeutics
03/2015
1Deep Brain Stimulation
12/2014
1Radiotherapy
02/2013